$35.93 (1.97%)

Volume: 35.779k

Closed: Dec 02, 2022

Hollow Logo Score: 2.111

Eagle Pharmaceuticals Stock Forecast

$35.93 (1.97%)

Volume: 35.779k

Closed: Dec 02, 2022

Score Hollow Logo 2.111

Eagle Pharmaceuticals Stock Statistics NASDAQ:EGRX

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior. Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average. Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Dates Signal Change
2022-11-23 - 2022-12-02 BUY -2.36
2022-11-22 - 2022-11-23 HOLD -0.608
2022-11-21 - 2022-11-22 SELL 2.75
2022-10-20 - 2022-11-21 BUY 24.71
2022-10-14 - 2022-10-20 HOLD 4.67

Stock Score Effectiveness

Bollinger Stock Signal Effectiveness

Macd Signal Effectiveness

Mv7 Signal Effectiveness

Score signal

Bollinger Signal Statistics

MV signal statistics

MACD Signal Statistics

Hot Stocks To Watch:

About Eagle Pharmaceuticals

Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin's lymphoma. Its product candidates also include EP-4104, a dantrolene sodium ... EGRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT